Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean oyebamiji oa[au] (1 results)?
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?
Oyebanji OA, Wilson B, Keresztesy D, Carias L, Wilk D, Payne M, Aung H, Denis KS, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Schmader KE, Balazs AB, King CL, Canaday DH, Gravenstein S. Oyebanji OA, et al. Aging Clin Exp Res. 2021 Nov;33(11):3151-3160. doi: 10.1007/s40520-021-01987-9. Epub 2021 Oct 15. Aging Clin Exp Res. 2021. PMID: 34652783 Free PMC article.
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
Canaday DH, Carias L, Oyebanji OA, Keresztesy D, Wilk D, Payne M, Aung H, St Denis K, Lam EC, Wilson B, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Balazs AB, Gravenstein S, King CL. Canaday DH, et al. Among authors: oyebanji oa. medRxiv. 2021 Mar 22:2021.03.19.21253920. doi: 10.1101/2021.03.19.21253920. Preprint. medRxiv. 2021. PMID: 33791727 Free PMC article. Updated.
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
Canaday DH, Carias L, Oyebanji OA, Keresztesy D, Wilk D, Payne M, Aung H, St Denis K, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Wilson B, Balazs AB, Gravenstein S, King CL. Canaday DH, et al. Among authors: oyebanji oa. Clin Infect Dis. 2021 Dec 6;73(11):2112-2115. doi: 10.1093/cid/ciab447. Clin Infect Dis. 2021. PMID: 33993265 Free PMC article.
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination.
Canaday DH, Oyebanji OA, White E, Keresztesy D, Payne M, Wilk D, Carias L, Aung H, St Denis K, Sheehan ML, Berry SD, Cameron CM, Cameron MJ, Wilson BM, Balazs AB, King CL, Gravenstein S. Canaday DH, et al. Among authors: oyebanji oa. medRxiv. 2021 Dec 7:2021.12.07.21267179. doi: 10.1101/2021.12.07.21267179. Preprint. medRxiv. 2021. PMID: 34909792 Free PMC article. Updated.
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents.
Canaday DH, Oyebanji OA, White E, Keresztesy D, Payne M, Wilk D, Carias L, Aung H, St Denis K, Sheehan ML, Berry SD, Cameron CM, Cameron MJ, Wilson BM, Balazs AB, King CL, Gravenstein S. Canaday DH, et al. Among authors: oyebanji oa. EBioMedicine. 2022 Jun;80:104066. doi: 10.1016/j.ebiom.2022.104066. Epub 2022 May 20. EBioMedicine. 2022. PMID: 35605428 Free PMC article.
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
Canaday DH, Oyebanji OA, Keresztesy D, Payne M, Wilk D, Carias L, Aung H, St Denis K, Lam EC, Rowley CF, Berry SD, Cameron CM, Cameron MJ, Wilson BM, Balazs AB, King CL, Gravenstein S. Canaday DH, et al. Among authors: oyebanji oa. Clin Infect Dis. 2022 Aug 24;75(1):e884-e887. doi: 10.1093/cid/ciab963. Clin Infect Dis. 2022. PMID: 35174389 Free PMC article.